Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
389
datasets available to search
ShareScore release 0.9.0
Dataset results
389 results for “Acute myeloid leukemia (AML)”
BLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 2- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With
ClinicalTrials.gov study NCT04284787. IPD Sharing: YES. Countries: 1. Publications: 0.
A Clinical Trial of Cytotoxic T Cells Augmenting Autologous Hematopoietic Stem Cell (AHSC) Transplantation for Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00808080. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Dose Escalation Study of GSK2879552 in Subjects With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02177812. IPD Sharing: YES. Countries: 3. Publications: 0.
Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00422591. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Trans
ClinicalTrials.gov study NCT00548847. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tipifarnib Versus Best Supportive Care in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00093990. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab for Maintenance Treatment in Subjects With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03154827. IPD Sharing: NO. Countries: 6. Publications: 0.
Volasertib in Japanese Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01662505. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03224819. IPD Sharing: YES. Countries: 3. Publications: 0.
A Study of ASP2215 (Gilteritinib) Combined With Atezolizumab in Patients With Relapsed or Treatment Refractory FMS-like Tyrosine Kinase (FLT3) Mutated Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03730012. IPD Sharing: NO. Countries: 1. Publications: 0.
Early Access Program (EAP) of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or With FLT3-Mutated AML in Complete
ClinicalTrials.gov study NCT03409081. IPD Sharing: Not stated. Countries: 3. Publications: 1.
BI 836858 Dose Escalation in Patients With Refractory or Relapsed Acute Myeloid Leukemia and in Patients With AML in Complete Remission With High Risk to Relapse
ClinicalTrials.gov study NCT01690624. IPD Sharing: NO. Countries: 1. Publications: 0.
Clofarabine Combinations in Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) and Myeloid Blast Phase Chronic Myeloid Leukemia (CML)
ClinicalTrials.gov study NCT00067028. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate MK-0482 for Relapsed/Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML) (MK-0482-002)
ClinicalTrials.gov study NCT05038800. IPD Sharing: YES. Countries: 3. Publications: 0.
Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrome (MDS) Patients
ClinicalTrials.gov study NCT00382590. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Investigation of genes involoved in Corydalis incisa (Thunb.) Pers. (CIP)-induced differentiation in acute myeloid leukemia (AML).
GEO Series GSE280425. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
Detection of mutant NPM1 mRNA in acute myeloid leukemia (AML) using custom gene expression arrays [Training cohort]
GEO Series GSE42194. Homo sapiens. 505 samples. Type: Other.
Gene expression data from sorted primary human acute myeloid leukemia (AML) samples
GEO Series GSE127200. Homo sapiens. 30 samples. Type: Expression profiling by array.
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14
GEO Series GSE97443. Homo sapiens. 8 samples. Type: Expression profiling by high throughput sequencing.
Integrative epigenomic analysis in MLL-AF9 acute myeloid leukemia (AML) and B-acute lymphoblastic leukemia (B-ALL)
GEO Series GSE70755. Homo sapiens. 9 samples. Type: Methylation profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.